このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

肥満外科手術後の個人における身体運動が筋質、体組成、および機能的反応に及ぼす影響 (BAR-EX)

2026年9月22日 更新者:María José Pabst、Universidad Autónoma de Chile

Effect of a Concurrent Exercise Program on Muscle Quality, Body Composition, Functional Response, and Quality of Life in Individuals Undergoing Bariatric Surgery: Protocol for a Randomized Controlled Clinical Trial

This study aims to evaluate the effect of a 5-week concurrent exercise program (aerobic and resistance training) on muscle quality, body composition, functional response, and quality of life in individuals undergoing bariatric surgery.

This is a single-center, prospective, longitudinal, randomized controlled clinical trial with two parallel groups: an intervention group and a control group. A total of 87 adults aged 18 to 60 years who have undergone sleeve gastrectomy or Roux-en-Y gastric bypass and have a medical indication for metabolic rehabilitation will be recruited.

The intervention group will participate in a structured, semi-supervised concurrent exercise program for 5 weeks, consisting of two in-person sessions per week (10 sessions in total), whereas the control group will continue receiving usual kinesiology care and standard clinical management according to the institutional rehabilitation protocol at Clínica BUPA Santiago. All participants will be assessed at two time points: baseline, during the fourth postoperative week, and at week 7.

The primary outcome will be the change in rectus femoris muscle quality assessed by ultrasound (echo intensity). Secondary outcomes will include body composition (bioelectrical impedance analysis), functional response (One-minute Sit-to-Stand Test), and quality of life (Moorehead-Ardelt II questionnaire).

Additionally, adherence to the exercise program in the intervention group will be assessed as the percentage of attendance at supervised exercise sessions, and its association with the magnitude of changes in study outcomes will be explored.

The findings are expected to provide clinically relevant evidence regarding the effectiveness of exercise during the early postoperative period and to contribute to the optimization of metabolic rehabilitation strategies following bariatric surgery.

調査の概要

詳細な説明

Bariatric surgery is an effective treatment for severe obesity; however, the early postoperative period is frequently associated with loss of lean body mass, reduced muscle strength, and functional decline, which may negatively affect recovery and quality of life. Physical exercise has been proposed as a key component of metabolic rehabilitation, although evidence regarding structured concurrent exercise programs initiated early after bariatric surgery remains limited, particularly with respect to muscle quality.

The aim of this study is to evaluate the effect of a 5-week concurrent exercise program on rectus femoris muscle quality in individuals undergoing bariatric surgery, compared with a control group receiving usual kinesiology care. Secondary objectives include evaluating changes in body composition, functional response, and quality of life, as well as exploring the association between exercise adherence and the magnitude of observed changes.

This is a single-center, prospective, longitudinal, randomized controlled clinical trial with two parallel groups (intervention and control). A total of 87 adults aged 18-60 years who have undergone sleeve gastrectomy or Roux-en-Y gastric bypass at Clínica BUPA Santiago and have a medical indication for metabolic rehabilitation will be recruited. Participants will undergo baseline assessment during the fourth postoperative week and will then be randomly allocated in a 1:1 ratio to the intervention or control group using a sequence generated and administered by an individual independent of the assessors and treating physical therapists.

The intervention group will participate in a structured, semi-supervised 5-week concurrent exercise program designed according to the FITT principle (Frequency, Intensity, Time, and Type of exercise). The program will combine aerobic and resistance training and will include two supervised in-person sessions per week (10 sessions in total) plus one complementary home-based session each week. Aerobic training will progress from continuous moderate-intensity exercise to interval training, whereas resistance training will progressively increase training volume for large muscle groups. Exercise intensity will be monitored using the Borg Rating of Perceived Exertion scale, and resistance loads will be individually adjusted according to each participant's clinical tolerance.

Participants allocated to the control group will continue receiving usual kinesiology care and standard clinical management according to the institutional metabolic rehabilitation protocol at Clínica BUPA Santiago. This program will also follow the FITT principle and will include two supervised sessions per week consisting of continuous aerobic exercise, targeted muscle strengthening, and static stretching, consistent with routine clinical practice, without the structured progression incorporated into the concurrent exercise program.

Following the 5-week intervention period, both groups will complete one week without supervised exercise sessions to minimize the acute effects of exercise on muscle measurements. Final assessments will be performed at week 7.

The primary outcome will be the change in rectus femoris muscle quality assessed by musculoskeletal ultrasound using echo intensity as the primary indicator. Secondary outcomes will include body composition assessed by bioelectrical impedance analysis, functional response assessed using the One-minute Sit-to-Stand Test, and quality of life assessed using the Moorehead-Ardelt II questionnaire.

Exercise adherence will be assessed exclusively in the intervention group as the percentage of attendance at supervised exercise sessions. The association between adherence and the magnitude of outcome changes will also be explored using a dose-response approach.

Statistical analyses will follow the intention-to-treat principle. The primary analysis will be performed using analysis of covariance (ANCOVA), with study group as the fixed factor and baseline values as covariates, adjusting for prespecified clinically relevant covariates when appropriate. Secondary outcomes will be analyzed using the same approach. Complementary analyses will include within- and between-group comparisons using parametric or non-parametric tests according to data distribution, estimation of effect sizes, and exploratory correlation and linear regression analyses to evaluate the association between exercise adherence and changes in study outcomes.

研究の種類

介入

入学 (推定)

87

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

研究場所

    • Santiago Metropolitan
      • Santiago、Santiago Metropolitan、チリ、7820830
        • 募集
        • Clínica BUPA, Santiago
        • コンタクト:
        • コンタクト:
        • 主任研究者:
          • Tomás Vergara Soria, Kinesiólogo

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~60年 (大人)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria

  • Adults aged 18-60 years.
  • Participants eligible for the institutional PAD (Pago Asociado a Diagnóstico) bariatric surgery program with medical indication for metabolic rehabilitation.
  • Undergoing sleeve gastrectomy or Roux-en-Y gastric bypass at Clínica BUPA Santiago.
  • Medical indication for metabolic rehabilitation.
  • Able and willing to provide written informed consent.

Exclusion Criteria

  • Type 1 diabetes mellitus or type 2 diabetes mellitus with severe complications (including stage G4-G5 nephropathy, severe autonomic neuropathy, or high risk of exercise-related hypoglycemia).
  • Severe musculoskeletal disorders limiting participation in the exercise program.
  • Acute cardiovascular event within the previous 3 months or medical contraindication to supervised exercise.
  • Severe cardiorespiratory disease or dyspnea at rest or with minimal exertion.
  • Dependence on supplemental oxygen.
  • Bariatric surgery complications (e.g., leak, bleeding, stenosis, or intra-abdominal abscess).
  • Liver failure, kidney failure, or any other clinical condition compromising safe participation in the exercise program.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:Concurrent Physical Exercise Program

Participants allocated to the intervention group will complete a structured, semi-supervised concurrent exercise program during the postoperative period following bariatric surgery. Participants will enter the study during postoperative week 4 and undergo a baseline assessment before starting the intervention. The program will last 5 weeks and will include 10 supervised in-person sessions (2 sessions/week, approximately 60 minutes each) and one complementary home-based session per week. After completion of the intervention, participants will remain one week without supervised exercise sessions before the week 7 follow-up assessment.

Concurrent physical exercise program of 5 weeks combining aerobic and resistance training in individuals undergoing bariatric surgery. The program includes two supervised in-person sessions per week (10 sessions total), each lasting approximately 60 minutes, and one recommended weekly home-based session guided by a prescribed exercise plan.

Aerobic exercise is performed at moderate to high intensity, monitored using the Borg Rating of Perceived Exertion scale. Resistance training targets major muscle groups and is prescribed based on an estimated one-repetition maximum (1RM), with progression in volume and intensity according to individual tolerance and safety criteria.

The program begins at postoperative week 4. After completing the 5-week intervention, participants undergo a 1-week period without supervised sessions before the post-intervention assessment.

他の名前:
  • Concurrent Physical Exercise Program
アクティブコンパレータ:Usual Metabolic Rehabilitation Program

Participants allocated to the control group will receive the usual metabolic rehabilitation program at Clínica BUPA Santiago. The rehabilitation program will follow the FITT principle (Frequency, Intensity, Time, and Type of exercise) and will include two supervised sessions per week for 5 weeks consisting of continuous aerobic exercise, targeted muscle strengthening, and stretching according to the institutional protocol. All participants will undergo baseline and week 7 assessments.

Usual institutional metabolic rehabilitation program at Clínica BUPA Santiago based on the FITT principle (Frequency, Intensity, Time, and Type of exercise). The program includes supervised continuous aerobic exercise, targeted muscle strengthening, and stretching delivered twice weekly for 5 weeks according to the institutional clinical protocol.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change in rectus femoris muscle quality (echo intensity; grayscale units 0-255)
時間枠:Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Muscle quality will be assessed by ultrasound as echo intensity (mean grayscale value, 0-255) within a standardized region of interest, analyzed using ImageJ, at baseline and post-intervention. Change will be calculated as Δ = post - pre.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

二次結果の測定

結果測定
メジャーの説明
時間枠
Change in percent body fat (%)
時間枠:Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Body composition will be assessed using bioelectrical impedance analysis (InBody S10) under standardized conditions before and after the intervention. Percent body fat (%) will be recorded at baseline and post-intervention. Change will be calculated as Δ = post - pre.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).
Change in fat mass (kg)
時間枠:Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Body composition will be assessed using bioelectrical impedance analysis (InBody S10) under standardized conditions before and after the intervention. Fat mass (kg) will be recorded at baseline and post-intervention. Change will be calculated as Δ = post - pre.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).
Change in skeletal muscle mass (kg)
時間枠:Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Body composition will be assessed using bioelectrical impedance analysis (InBody S10) under standardized conditions before and after the intervention. Skeletal muscle mass (kg) will be recorded at baseline and post-intervention. Change will be calculated as Δ = post - pre.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).
Change in 1-minute Sit-to-Stand performance (1min-STST)
時間枠:Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Functional response will be assessed using the One-minute Sit-to-Stand Test (1min-STST). The primary metric is the total number of completed repetitions in 60 seconds performed using a standard chair. Perceived exertion (modified Borg scale) may be recorded as a complementary measure.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).
Adherence to the exercise program (supervised in-clinic sessions)
時間枠:During the 5-week intervention period (calculated at the end of the program based on attendance to the 10 supervised sessions).

Attendance rate to supervised in-clinic sessions at Clínica BUPA during the intervention. Adherence will be calculated as: adherence (%) = (number of attended sessions / 10) × 100. For descriptive purposes, adherence will be categorized as high (8-10 sessions; ≥80%), moderate (6-7 sessions; 60-79%), and low (0-5 sessions; <60%). Adherence ≥80% will be considered clinically acceptable.

During the 5-week intervention period (calculated at the end of the program based on attendance to the 10 supervised sessions).
Change in visceral fat area (cm²)
時間枠:Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Body composition will be assessed using bioelectrical impedance analysis (InBody S10) under standardized conditions before and after the intervention. Visceral fat area (cm²) will be recorded at baseline and post-intervention. Change will be calculated as Δ = post - pre.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).
Change in basal metabolic rate (kcal/day)
時間枠:Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Body composition will be assessed using bioelectrical impedance analysis (InBody S10) under standardized conditions before and after the intervention. Basal metabolic rate (kcal/day) will be recorded at baseline and post-intervention. Change will be calculated as Δ = post - pre.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).
Change in rectus femoris muscle thickness (cm)
時間枠:Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

ectus femoris muscle thickness (cm) will be assessed by ultrasound under standardized conditions at baseline and post-intervention. Change will be calculated as Δ = post - pre.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).
Change in rectus femoris cross-sectional area (cm²)
時間枠:Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Rectus femoris cross-sectional area (cm²) will be assessed by ultrasound under standardized conditions at baseline and post-intervention. Change will be calculated as Δ = post - pre

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).
Change in intramuscular fat infiltration assessed by ultrasound echo intensity (grayscale units 0-255)
時間枠:Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of intervention and 1 week of rest).

Intramuscular fat infiltration will be assessed by musculoskeletal ultrasound using rectus femoris echo intensity (grayscale units 0-255) under standardized acquisition conditions. Images will be analyzed using ImageJ. Change will be calculated as Δ = post - pre.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of intervention and 1 week of rest).
Change in quality of life assessed by the Moorehead-Ardelt II questionnaire
時間枠:Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Quality of life will be assessed using the Moorehead-Ardelt II questionnaire, a bariatric surgery-specific instrument that evaluates domains including self-esteem, physical well-being, social relationships, work, and sexuality. Total score (and domain scores, if applicable) will be compared before and after the intervention.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:María José Pabst Pérez, MSc、Universidad Autónoma de Chile
  • スタディチェア:Luis Astete, MSc、Universidad Autónoma de Chile
  • スタディチェア:Nicolas Arancibia Ramirez, Kinesiólogo、Clinica Alemana
  • スタディディレクター:Rosario Alonso Domínguez, PhD.、Universidad de Salamanca. España
  • スタディディレクター:María de la Luz Tocino, PhD.、University of Salamanca
  • スタディディレクター:Matias Otto Yañez, PhD.、Universidad Autónoma de Chile. Chile
  • スタディチェア:Paloma Lillo, MsC、Universidad Silva Henriquez
  • スタディチェア:Carla Martinez Dominguez, Kinesióloga、Clinica Bupa Santiago
  • 主任研究者:Tomás Vergara Soria, Kinesiólogo、Clínica BUPA Santiago
  • スタディチェア:Sebastian Barrios Valenzuela, Kinesiólogo、Clínica BUPA Santiago
  • スタディチェア:Erika Troncoso, MsC、Clinica las Condes
  • スタディチェア:Karen Castañeda Lavin, MsC、University of Americas - Chili

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2025年8月11日

一次修了 (推定)

2027年12月31日

研究の完了 (推定)

2028年12月31日

試験登録日

最初に提出

2025年11月14日

QC基準を満たした最初の提出物

2026年2月17日

最初の投稿 (実際)

2026年2月20日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月25日

QC基準を満たした最後の更新が送信されました

2026年9月22日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

Individual participant data (IPD) will not be publicly shared to protect patient confidentiality. Only aggregated and anonymized results will be disseminated through scientific publications or presentations.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する